BIOMARIN PHARMACEUTICAL INC

Develops and commercializes therapies for rare, life-threatening genetic diseases.

BMRN | US

Overview

Corporate Details

ISIN(s):: US09061G1013
LEI:
Country:: United States of America
Address:: 105 DIGITAL DRIVE, 94949 NOVATO
Website:: https://www.biomarin.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioMarin Pharmaceutical Inc. is a global biotechnology company dedicated to developing and commercializing transformative therapies for rare and life-threatening genetic diseases. Founded in 1997, the company leverages its scientific expertise in the underlying causes of genetic conditions to create first-in-class and best-in-class treatments. Its portfolio of marketed products addresses disorders such as achondroplasia, severe hemophilia A, and various lysosomal storage diseases, often utilizing enzyme replacement therapies (ERTs) and other advanced modalities. BioMarin also maintains an active pipeline of investigational medicines in various stages of clinical and preclinical development to address unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOMARIN PHARMACEUTICAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOMARIN PHARMACEUTICAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOMARIN PHARMACEUTICAL INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
JW LIFESCIENCE CORPORATION A leading developer and manufacturer of infusion solutions, from basic IV fluids to complex nutrients.	South Korea	234080
JW SHINYAK CORPORATION Develops specialty medicines for the dermatology, urology, and otolaryngology clinical markets.	South Korea	067290
Jyong Biotech Ltd. Develops plant-derived drugs for urinary system diseases, with a lead candidate in Phase III trials.	United States of America	MENS
Kadimastem Ltd. Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.	Israel	KDST
kainos loboratories,inc Develops, manufactures, and sells innovative clinical diagnostic reagents for the healthcare industry.	Japan	4556
Kairos Pharma, LTD. Develops novel oncology therapies to reverse drug resistance and immune suppression.	United States of America	KAPA
KAKEN PHARMACEUTIAL CO., LTD. R&D pharma firm creating drugs & devices for orthopedics, dermatology, and surgery globally.	Japan	4521
KALA BIO, Inc. Developing stem cell-based biologics for rare and serious eye diseases.	United States of America	KALA
Kalaris Therapeutics, Inc. Developing next-gen, long-acting anti-VEGF therapies for prevalent retinal diseases.	United States of America	KLRS
KalVista Pharmaceuticals, Inc. Developing oral protease inhibitors for rare diseases like hereditary angioedema (HAE).	United States of America	KALV